The acne vulgaris market reached a value of US$ 7.0 Billion in 2023 and is anticipated to grow at a CAGR of 3.23% to more than $10 billion by 2034, according to a report by the IMARC Group. 

The rising popularity of light-based and laser therapies is partially responsible for this growth, according to a news release, as is the rising popularity of blue light therapy and laser resurfacing The report provided an analysis of acne vulgaris market across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan, looking at treatment methods, available drugs, drugs in development, market share of therapies, and market performance across regions. Key market drivers, according to the report, included increasing awareness and concerns about personal appearance, leading to a demand for effective acne treatments.

The report also cited the prevalence of acne among adolescents and adults as a key contributor to market expansion. The integration of acne-fighting ingredients into mainstream beauty products was also cited as a propellant for market growth. Sedentary lifestyles and dietary patterns were also called out as triggers for acne, further driving demand for products addressing underlying causes.

Source: IMARC press release. May 6, 2024.